Healthcare provider profile · identity verified

Jaime Duque, MD

General Practice · MIAMI, FL · NPI 1457463689

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	648	191
Alprazolam	Alprazolam	515	68
Losartan Potassium	Losartan Potassium	501	142
Levothyroxine Sodium	Levothyroxine Sodium	412	110
Lorazepam	Lorazepam	408	51
Amlodipine Besylate	Amlodipine Besylate	405	121
Rosuvastatin Calcium	Rosuvastatin Calcium	378	108
Gabapentin	Gabapentin	349	90
Metoprolol Succinate	Metoprolol Succinate	330	89
Alcohol Prep Pads	Alcohol Antiseptic Pads	316	71
Omeprazole	Omeprazole	313	88
Fluticasone Propionate	Fluticasone Propionate	292	84
Lisinopril	Lisinopril	289	84
Eliquis	Apixaban	285	56
Pantoprazole Sodium	Pantoprazole Sodium	267	86
Metformin Hcl	Metformin Hcl	252	76
Temazepam	Temazepam	247	36
Hydrochlorothiazide	Hydrochlorothiazide	243	64
Albuterol Sulfate Hfa	Albuterol Sulfate	234	44
Famotidine	Famotidine	220	66
Simvastatin	Simvastatin	212	63
Tamsulosin Hcl	Tamsulosin Hcl	202	52
Furosemide	Furosemide	180	51
Metoprolol Tartrate	Metoprolol Tartrate	179	52
Sertraline Hcl	Sertraline Hcl	173	36
Alendronate Sodium	Alendronate Sodium	166	49
Clonazepam	Clonazepam	166	24
Clopidogrel	Clopidogrel Bisulfate	166	47
Escitalopram Oxalate	Escitalopram Oxalate	160	49
Memantine Hcl	Memantine Hcl	157	39
Trazodone Hcl	Trazodone Hcl	151	45
Buspirone Hcl	Buspirone Hcl	136	38
Donepezil Hcl	Donepezil Hcl	135	36
Montelukast Sodium	Montelukast Sodium	129	39
Carvedilol	Carvedilol	128	35
Finasteride	Finasteride	111	30
Latanoprost	Latanoprost	96	26
Mirtazapine	Mirtazapine	93	19
Ezetimibe	Ezetimibe	92	24
Lactulose	Lactulose	91	27
Enalapril Maleate	Enalapril Maleate	87	22
Quetiapine Fumarate	Quetiapine Fumarate	86	22
Atenolol	Atenolol	75	23
Dicyclomine Hcl	Dicyclomine Hcl	74	19
Clonidine Hcl	Clonidine Hcl	73	31
Ketoconazole	Ketoconazole	72	20
Felodipine Er	Felodipine	67	17
Glipizide Er	Glipizide	66	14
Glimepiride	Glimepiride	64	16
Oxybutynin Chloride Er	Oxybutynin Chloride	64	13
Sildenafil Citrate	Sildenafil Citrate	63	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	61	11
Azithromycin	Azithromycin	59	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	18
Prednisone	Prednisone	58	26
Diclofenac Sodium	Diclofenac Sodium	57	22
Fluoxetine Hcl	Fluoxetine Hcl	54	15
Linzess	Linaclotide	54	suppressed
Symbicort	Budesonide/Formoterol Fumarate	53	suppressed
Allopurinol	Allopurinol	51	16
Bumetanide	Bumetanide	51	15
Duloxetine Hcl	Duloxetine Hcl	51	11
Chlorthalidone	Chlorthalidone	50	12
Pregabalin	Pregabalin	50	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	12
Lumigan	Bimatoprost	47	12
Pravastatin Sodium	Pravastatin Sodium	47	15
Amiodarone Hcl	Amiodarone Hcl	45	suppressed
Fenofibrate	Fenofibrate	44	16
Lovastatin	Lovastatin	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	11
Nifedipine Er	Nifedipine	41	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	24
Sps	Sodium Polystyrene Sulfon/Sorb	40	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	39	suppressed
Xarelto	Rivaroxaban	38	suppressed
Pentoxifylline	Pentoxifylline	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Novolog Flexpen	Insulin Aspart	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	11
Potassium Chloride	Potassium Chloride	33	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	11
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Lansoprazole	Lansoprazole	31	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	13
Meclizine Hcl	Meclizine Hcl	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	13
Acarbose	Acarbose	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Ciclopirox	Ciclopirox	28	15
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Risedronate Sodium	Risedronate Sodium	28	suppressed
Sucralfate	Sucralfate	28	11
Vascepa	Icosapent Ethyl	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	26	26
Ibuprofen	Ibuprofen	26	11
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Baclofen	Baclofen	25	13
Isosorbide Dinitrate	Isosorbide Dinitrate	25	suppressed
Glipizide	Glipizide	24	suppressed
Digoxin	Digoxin	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Gemfibrozil	Gemfibrozil	23	suppressed
Indapamide	Indapamide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Hydrocortisone	Hydrocortisone	22	13
Irbesartan	Irbesartan	22	suppressed
Risperidone	Risperidone	22	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Amoxicillin	Amoxicillin	21	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	20
Galantamine Er	Galantamine Hbr	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Clotrimazole	Clotrimazole	19	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Nystatin	Nystatin	19	11
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	19
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Combigan	Brimonidine Tartrate/Timolol	18	suppressed
Cromolyn Sodium	Cromolyn Sodium	18	11
Megestrol Acetate	Megestrol Acetate	18	suppressed
Methimazole	Methimazole	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Mupirocin	Mupirocin	17	13
Ssd	Silver Sulfadiazine	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Nitroglycerin Patch	Nitroglycerin	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Galantamine Hbr	Galantamine Hbr	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	13
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error